Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
debts
Pharma
Bayer's corporate overhaul faces new questions after trial flop
Bayer's twin losses in court and in the clinic this week could hamstring the company's ability to tweak its corporate structure, analysts argue.
Fraiser Kansteiner
Nov 21, 2023 4:37pm
Amicus scores $430M financing deal with asset manager Blackstone
Oct 2, 2023 4:16pm
Zevra is buying rare disease compatriot Acer for $91M
Aug 31, 2023 10:55am
In debt again, Glenmark seeks buyer for its API business: report
Apr 11, 2023 10:27am
Arcutis secures $225M ahead of critical year for topical tech
Jan 4, 2022 7:45am
Teva shares approach 20-year low amid Moody's warning
Aug 15, 2019 11:15am
